ASCAL Tablets Effervescent 100 Milligram
Country: Ireland
Bahasa: Inggeris
Sumber: HPRA (Health Products Regulatory Authority)
Ciri produk
(SPC)
04-05-2024
Beberapa dokumen untuk produk ini saat ini tidak tersedia, anda dapat mengirim permintaan ke layanan pelanggan kami dan kami akan memberitahu Anda segera setelah kami dapat memperolehnya.
Hantar permintaan.
Hantar permintaan.
Bahan aktif:
CARBASALATE CALCIUM
Boleh didapati daripada:
Meda Health Sales Ireland Limited
Dos:
100 Milligram
Borang farmaseutikal:
Tablets Effervescent
Tarikh kebenaran:
2006-06-13
Ciri produk
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Ascal Brisper Cardio-Neuro 100 mg effervescent tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
One effervescent tablet contains 100 mg carbasalate calcium, corresponding to 78 mg acetyl salicylic acid.
Excipient: contains Lactose Monohydrate 150.0 mg.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Effervescent tablet.
White- to cream-coloured, round, flat tablet with bevelled edge.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Ascal is indicated for secondary prevention after a first myocardial or cerebrovascular event linked to atherosclerosis :
•
Myocardial infarction
•
Unstable and stable angina pectoris
•
Stroke and transient ischaemic attack provided that intracanial haemorrhages are excluded.
•
Graft occlusion after aorta-coronary bypass.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
_Secondary prevention of myocardial infarction:_
In acute cases a loading dose of an initial 2 effervescent tablets (200 mg carbasalate calcium, corresponding to 156 mg
acetylsalicylic acid) per day should be taken on the first day, followed by 1 to 2 effervescent tablets (100 mg carbasalate
calcium, corresponding to 78 mg acetylsalicylic acid, to 200 mg carbasalate calcium, corresponding to 156 mg
acetylsalicylic acid) per day. In acute cases, the first dose must be taken as soon as possible after the diagnosis.
_Secondary prevention of unstable and stable angina pectoris:_
In acute cases a loading dose of an initial 2 effervescent tablets (200 mg carbasalate calcium, corresponding to 156 mg
acetylsalicylic acid) per day should be taken on the first day, followed by 1 to 2 effervescent tablets (100 mg carbasalate
calcium, corresponding to 78 mg acetylsalicylic acid, to 200 mg carbasalate calcium,
Baca dokumen lengkap
